{
  "figure_1": "Diagnostic distribution of haematological malignancies and precursor conditions classified by ICD-O-3, Haematological Malignancy Research Network, 2004–2016",
  "figure_2": "National data availability: Haematological Malignancy Research Network patient cohort and comparison cohort",
  "figure_3": "Annual rheumatology outpatient episode rates (95% confidence intervals) in the 10 years before diagnosis of diffuse large B-cell lymphoma (cases) or pseudo-diagnosis (controls): Haematological Malignancy Research Network diagnoses, 2009–2015",
  "figure_4": "Monthly outpatient attendance rates (per 100 persons) in cases and controls, and rate ratios by outpatient specialty with at least two visits (A) in the 3 years before diagnosis and (B) in the 3 years after diagnosis of monoclonal gammopathy of undetermined significance (MGUS)"
}